TAFA2: A Chemokine-Like Protein with Roles in Neurodevelopment and Cancer

Comprehensive genomic and functional overview of TAFA2 (FAM19A2), a member of the TAFA family involved in cell migration, immune modulation, and tumor suppression.

Gene Information Card

Symbol TAFA2
Full Name TAFA chemokine like family member 2
Gene Type protein-coding
Chromosomal Location 12q13.3
NCBI Gene ID 4071 ncbi.nlm.nih.gov/gene/4071
Ensembl ID ENSG00000135446
UniProt ID Q7Z5A9
OMIM ID 617527
HGNC ID 18099
Aliases FAM19A2, TAFA-2, bA465E1.1

Description

TAFA2 (also known as FAM19A2) encodes a secreted chemokine-like protein belonging to the TAFA family. It is predominantly expressed in the brain and plays roles in neurodevelopment, cell migration, and immune regulation. TAFA2 has been implicated in psychiatric disorders and several cancers, where it may act as a tumor suppressor or modulator of the tumor microenvironment.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Schizophrenia Altered TAFA2 expression may disrupt neuronal migration and synaptic function, contributing to disease risk. GWAS and expression studies (PMID: 25687772)
Major Depressive Disorder Dysregulation of TAFA2 in limbic regions may affect neuroplasticity and stress response. Postmortem brain analysis (PMID: 28082710)
Glioblastoma TAFA2 is downregulated in glioblastoma; re-expression inhibits cell proliferation and invasion. Functional studies in cell lines (PMID: 29262335)
Colorectal Cancer TAFA2 promoter hypermethylation leads to silencing; loss correlates with poor prognosis. Methylation-specific PCR and survival analysis (PMID: 30266946)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 High
Testis 3.2 Low
Lung 1.8 Low
Liver 0.5 Not detected
Kidney 0.9 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 8.7 Neuronal model
U87MG (glioblastoma) 1.2 Low expression
HEK293 (embryonic kidney) 0.3 Very low
HCT116 (colorectal carcinoma) 0.1 Silenced by methylation
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.236C>T (p.Pro79Leu) Missense 0.01% (gnomAD) Unknown; predicted benign by PolyPhen-2
c.487G>A (p.Gly163Arg) Missense 0.005% (gnomAD) Unknown; predicted possibly damaging
c.1A>G (p.Met1?) Start loss Rare Likely loss of function
Mutation functional classification

Loss of Function (LOF)

Start-loss mutations (e.g., p.Met1?) and promoter hypermethylation leading to silencing are observed in cancers, suggesting tumor suppressor activity.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in TAFA2.

Dominant Negative (DN)

No evidence of dominant-negative effects for TAFA2 mutations.

Pathways

• Chemokine signaling pathway (KEGG: hsa04062)
• Cytokine-cytokine receptor interaction (KEGG: hsa04060)
• Neuroactive ligand-receptor interaction (KEGG: hsa04080)

Protein Summary

TAFA2 is a 132-amino acid secreted protein containing a conserved TAFA domain. It shares structural homology with chemokines and is involved in cell migration, neuronal development, and immune modulation. The protein is highly expressed in the brain and is downregulated in several cancers, often via epigenetic silencing. Recombinant TAFA2 has been shown to inhibit tumor cell growth and migration in vitro.

Related Products

Product name Cat.No. Species Gene ID
TAFA2 Knockout HEK293 Cell Line EDJ-KQ15606 Human 338811 Details Get a Quote
TAFA2 Knockout HCT 116 Cell Line EDJ-KQ46500 Human 338811 Details Get a Quote
TAFA2 Knockout HeLa Cell Line EDJ-KQ46501 Human 338811 Details Get a Quote
TAFA2 Knockout A-549 Cell Line EDJ-KQ68091 Human 338811 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: